Endonovo Therapeutics Inc. (ENDV) Offers Bright Spot in Opioid -Addiction Space with New Pain-Management Option
ENDV has developed a viable pain-control solution for those seeking alternatives to highly addictive opioids The company’s flagship product is an FDA-cleared, easy-to-place, noninvasive device that delivers pulsed electromagnetic frequencies to targeted area In one study, patients treated with Endonovo technology reported a decrease in pain medication by nearly threefold Amid mounting concern about the alarming opioid-addiction crisis, Endonovo Therapeutics Inc. (OTCQB: ENDV) offers one of the few bright spots on the horizon. Endonovo is the commercial-stage developer of noninvasive Electroceutical(TM) Therapeutic devices designed to target patient pain and inflammation, a viable pain-control solution for those desperately seeking options other than highly…